← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Coare Biotechnology, Inc.
Oklahoma City, OK
$2,816,102
Total funding
4
Grants
Funding over time
peak $1.1M · FY2013–17$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,816,102 · 4
By mechanism
R44$2,000,000 · 1
R43$816,102 · 3
Investigators at Coare Biotechnology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Monoclonal Antibodies to Treat Pancreatic Cancer$1,094,011
R44 · FY2017 · CA
Development of Monoclonal Antibodies to Treat Pancreatic Cancer$905,989
R44 · FY2016 · CA
Development of an ADC against Pancreatic Cancer$225,000
R43 · FY2015 · CA
Development of ADC to Target Tumor Stem Cells In Colorectal Cancer$224,950
R43 · FY2015 · CA
Development of Monoclonal Antibodies To Treat Pancreatic Cancer$220,099
R43 · FY2013 · CA
Development of Monoclonal Antibodies To Treat Pancreatic Cancer$146,053
R43 · FY2014 · CA